Porter Adventist Hospital is a 368-bed acute care hospital located in the University of Denver/Harvard Park area of Denver, Colorado. Porter Adventist specializes in treating patients with cardiac care, cancer care, joint replacement, behavioral health, spinal care and transplant needs.

There are 368 beds in Porter Adventist Hospital.

During the past decade, Porter Adventist Hospital conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 160 clinical trials were completed, i.e. on average, 115.9% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 61 clinical trials were completed. i.e. 160.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Porter Adventist Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 150 trials, followed by "Alliance for Clinical Trials in Oncology" with 70 trials sponsored, "SWOG Cancer Research Network" with 42 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 24 trials sponsored and "Eastern Cooperative Oncology Group" with 24 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Porter Adventist Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 207 trials as a collaborator, "NRG Oncology" with 41 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator and "NCIC Clinical Trials Group" with 10 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Porter Adventist Hospital" are "Breast Cancer" (30 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lung Cancer" (13 trials), "Lymphoma" (13 trials) and "Recurrent Breast Carcinoma" (12 trials). Many other conditions were trialed in "Porter Adventist Hospital" in a lesser frequency.

Most popular intervention types in "Porter Adventist Hospital" are "Drug" (301 trials), "Other" (190 trials), "Biological" (155 trials), "Procedure" (70 trials) and "Radiation" (66 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (86 trials), "Quality-of-Life Assessment" (68 trials), "Questionnaire Administration" (39 trials), "Paclitaxel" (38 trials) and "Carboplatin" (34 trials). Other intervention names were less common.

The vast majority of trials in "Porter Adventist Hospital" are 295 trials for "All" genders, 60 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Porter Adventist Hospital". undefined are not yet recruiting, 69 are recruiting, 131 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 141 completed trials in Porter Adventist Hospital, 4 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Porter Adventist Hospital, 7 "Phase 1" clinical trials were conducted, 162 "Phase 2" clinical trials and 200 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".